Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. It can positively transform the lives of people living with severe and life-threatening diseases. IIntellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a broad pipeline toward clinical development, including ex Vivo, and in vivo approaches.  Intellia Therapeutics was formed in 2014 and is headquartered in Cambridge, Massachusetts.

Marketing & Communications

Legal

Sales & Business Development

Operations

Customer Service

Cambridge, MA, USA

Intellia Therapeutics

Biotech

100 - 1,000

MIT Startup Exchange (STEX), a MIT Corporate Relations program, connects industry and startups.

Massachusetts Institute of Technology

MIT Sloan Career Development Office

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Massachusetts Institute of Technology Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Massachusetts Institute of Technology network as they come up.

You can always update this information later.

Welcome to the Massachusetts Institute of Technology talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Massachusetts Institute of Technology company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.